AGAPE ATP CORPORATION Deferred Foreign Income Tax Expense (Benefit)
AGAPE ATP CORPORATION (ATPC) reported Deferred Foreign Income Tax Expense (Benefit) of -$220 for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2025-03-31
- AGAPE ATP CORPORATION deferred foreign income tax expense (benefit) for the quarter ending 2023-12-31 was $6.32K.
- AGAPE ATP CORPORATION deferred foreign income tax expense (benefit) for the quarter ending 2023-09-30 was $3.94K.
- AGAPE ATP CORPORATION deferred foreign income tax expense (benefit) for the quarter ending 2023-06-30 was -$2.44K.
- AGAPE ATP CORPORATION deferred foreign income tax expense (benefit) for the quarter ending 2023-03-31 was -$4.22K.
- AGAPE ATP CORPORATION deferred foreign income tax expense (benefit) for fiscal 2023 was -$220.00.
- AGAPE ATP CORPORATION deferred foreign income tax expense (benefit) for fiscal 2022 was -$15.02K, a 248.29% decline from fiscal 2021.
- AGAPE ATP CORPORATION deferred foreign income tax expense (benefit) for fiscal 2021 was $10.13K, a 94.32% decline from fiscal 2020.
- AGAPE ATP CORPORATION deferred foreign income tax expense (benefit) for fiscal 2020 was $178.33K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 3 month | Deferred Foreign Income Tax Expense (Benefit) 3 month as first filed | Deferred Foreign Income Tax Expense (Benefit) 6 month | Deferred Foreign Income Tax Expense (Benefit) 6 month as first filed | Deferred Foreign Income Tax Expense (Benefit) 9 month | Deferred Foreign Income Tax Expense (Benefit) 9 month as first filed | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $6.32K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $10.26K derived: sum of 2 quarters · filed 2025-03-31 | $7.82K derived: sum of 3 quarters · filed 2025-03-31 | -$220.00 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $3.94K 10-Q · filed 2024-11-14 | $1.50K derived: sum of 2 quarters · filed 2024-11-14 | -$6.54K 10-Q · filed 2024-11-14 | -$2.83K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$2.44K 10-Q · filed 2024-08-14 | -$6.66K 10-Q · filed 2024-08-14 | -$6.77K derived: sum of 3 quarters · filed 2024-08-14 | |||||
| 2023-03-31 | -$4.22K 10-Q · filed 2024-05-14 | -$4.33K derived: sum of 2 quarters · filed 2024-05-14 | ||||||
| 2022-12-31 | -$114.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$15.02K 10-K · filed 2024-04-01 | ||||||
| 2022-09-30 | -$14.90K 10-Q · filed 2023-11-14 | |||||||
| 2021-12-31 | $141.76K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $63.43K derived: sum of 2 quarters · filed 2023-03-31 | $30.73K derived: sum of 3 quarters · filed 2023-03-31 | $10.13K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$78.33K 10-Q · filed 2022-11-14 | $78.33K 10-Q · filed 2021-11-12 | -$111.03K derived: sum of 2 quarters · filed 2022-11-14 | -$131.63K 10-Q · filed 2022-11-14 | $131.63K 10-Q · filed 2021-11-12 | $218.32K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$32.70K 10-Q · filed 2022-08-11 | $32.70K 10-Q · filed 2021-08-13 | -$53.30K 10-Q · filed 2022-08-11 | $53.30K 10-Q · filed 2021-08-13 | $296.66K derived: sum of 3 quarters · filed 2022-08-11 | $259.10K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$20.60K 10-Q · filed 2022-05-13 | $20.60K 10-Q · filed 2021-05-17 | $329.35K derived: sum of 2 quarters · filed 2022-07-05 | $291.79K derived: sum of 3 quarters · filed 2022-07-05 | $157.72K derived: sum of 4 quarters · filed 2022-07-05 | |||
| 2020-12-31 | $349.96K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | $312.40K derived: sum of 2 quarters · filed 2022-07-05 | $178.33K derived: sum of 3 quarters · filed 2022-07-05 | $178.33K 10-K/A · filed 2022-07-05 | -$178.33K 10-K · filed 2021-03-31 | |||
| 2020-09-30 | -$37.56K 10-Q/A · filed 2022-07-05 | -$171.63K derived: sum of 2 quarters · filed 2022-07-05 | -$171.63K 10-Q/A · filed 2022-07-05 | |||||
| 2020-06-30 | -$134.07K 10-Q · filed 2021-08-13 | -$134.07K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |